84 related articles for article (PubMed ID: 8357971)
1. Bone marrow-derived dendritic cells and the protection against X-ray-induced thymic leukemia in mice. A new interpretation.
Becker Y; Sprecher E; Bentov I; Berkowitz C
In Vivo; 1993; 7(3):281-4. PubMed ID: 8357971
[TBL] [Abstract][Full Text] [Related]
2. Cellular events during radiation-induced thymic leukemogenesis in mice: abnormal T cell differentiation in the thymus and defect of thymocyte precursors in the bone marrow after split-dose irradiation.
Muto M; Kubo E; Sado T
J Immunol; 1985 Mar; 134(3):2026-31. PubMed ID: 3871460
[TBL] [Abstract][Full Text] [Related]
3. Effects of marrow grafting on preleukemia cells and thymic nurse cells in C57BL/Ka mice after a leukemogenic split-dose irradiation.
Defresne MP; Greimers R; Lenaerts P; Boniver J
J Natl Cancer Inst; 1986 Nov; 77(5):1079-85. PubMed ID: 3534425
[TBL] [Abstract][Full Text] [Related]
4. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
5. Cytofluorometric analysis of thymic interdigitating cells from C57BL/6 mice prior and after leukemogenic X-irradiation.
Sprecher E; Giloh H; Rahamim E; Yefenof E; Becker Y
Leuk Res; 1989; 13(9):799-809. PubMed ID: 2796385
[TBL] [Abstract][Full Text] [Related]
6. Development of prelymphoma cells committed to thymic lymphomas during radiation-induced thymic lymphomagenesis in B10 mice.
Muto M; Kubo E; Sado T
Cancer Res; 1987 Jul; 47(13):3469-72. PubMed ID: 3495331
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas.
Melero I; Duarte M; Ruiz J; Sangro B; Galofré J; Mazzolini G; Bustos M; Qian C; Prieto J
Gene Ther; 1999 Oct; 6(10):1779-84. PubMed ID: 10516729
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
[TBL] [Abstract][Full Text] [Related]
9. Stages in the development of radiation-induced thymic lymphomas in C57 BL/Ka mice: preleukemic cells become progressively resistant to the tumor preventing effects of a bone marrow graft.
Humblet C; Greimers R; Boniver J; Defrense MP
Exp Hematol; 1997 Feb; 25(2):109-13. PubMed ID: 9015210
[TBL] [Abstract][Full Text] [Related]
10. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
11. [Lympho-epithelial interactions in the thymus during development of radio-induced lymphomas in C57BL mice].
Houben-Defresne MP; Lenaerts P; Greimers R; Boniver J
C R Seances Soc Biol Fil; 1984; 178(2):195-202. PubMed ID: 6235898
[TBL] [Abstract][Full Text] [Related]
12. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
[TBL] [Abstract][Full Text] [Related]
13. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
[TBL] [Abstract][Full Text] [Related]
14. [Migration of bone marrow cells toward the thymus in C57BL/Ka under fractionated irradiation].
Humblet C; Defresne MP; Greimers R; Rongy AM; Boniver J
C R Seances Soc Biol Fil; 1987; 181(4):426-31. PubMed ID: 2963680
[TBL] [Abstract][Full Text] [Related]
15. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
Haran-Ghera N; Ben-Yaakov M; Peled A
J Immunol; 1977 Feb; 118(2):600-6. PubMed ID: 320261
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells prevent radiation-induced thymic lymphoma.
Potworowski EF; Gagnon F; Beauchemin C; St Pierre Y
Leukemia; 1996 Oct; 10(10):1639-47. PubMed ID: 8847899
[TBL] [Abstract][Full Text] [Related]
17. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
Yang AS; Lattime EC
Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
[TBL] [Abstract][Full Text] [Related]
19. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice.
Szabo P; Zhao K; Kirman I; Le Maoult J; Dyall R; Cruikshank W; Weksler ME
J Immunol; 1998 Sep; 161(5):2248-53. PubMed ID: 9725218
[TBL] [Abstract][Full Text] [Related]
20. Immunodepression, a noncontributor to radiation-induced leukemogenesis of the RFM mouse.
Perkins EH; Cacheiro LH
Cancer Res; 1980 Feb; 40(2):357-61. PubMed ID: 6965356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
